Search Within

Computational Oncology Service

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (145)
  2. Meeting Abstract (99)
  3. Editorial (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (247)
  2. Epidemiology and Biostatistics (247)
  3. GSK Faculty (247)
  4. Genitourinary Oncology Service (247)
  5. Solid Tumor Oncology Division (247)
  6. Human Oncology and Pathogenesis Program (238)

More Groups

People
  1. Nikolaus Schultz (191)
  2. David Solit (165)
  3. Michael Berger (128)
  4. Marc Ladanyi (59)
  5. Ahmet Zehir (55)
  6. Barry Taylor (48)

More People

Years
  1. 2025 (8)
  2. 2024 (18)
  3. 2023 (16)
  4. 2022 (28)
  5. 2021 (23)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (62)
  2. Clinical Cancer Research (27)
  3. Cancer Research (21)
  4. Cancer Discovery (11)
  5. European Urology (11)
  6. JCO Precision Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (71)
  2. American Association for Cancer Research (63)
  3. Nature Publishing Group (27)
  4. Elsevier Science, Inc. (13)
  5. Oxford University Press (13)
  6. Cell Press (11)

More Publishers

Results (247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Peroxisome proliferator-activated receptor gamma (PPARG) gene amplifications in urothelial carcinoma (UC)
    Meeting Abstract

    Bambury, R. M.; Iyer, G.; Riester, M.; Werner, L.; Schultz, N.; Stack, E. C.; Park, R.; Loda, M.; Ostrovnaya, I.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Furberg, H.; Zabor, E. C.; Jacobsen, A.; Schultz, N.; Ciriello, G.; Mikkilineni, N.; Fiegoli, B.; Kim, P. H.; Voss, M. H.; more...
    JNCI: Journal of the National Cancer Institute (2013)

    Fulltext@MSK | Save
  • Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
    Journal Article

    Iyer, G.; Al-Ahmadie, H.; Schultz, N.; Hanrahan, A. J.; Ostrovnaya, I.; Balar, A. V.; Kim, P. H.; Lin, O.; Weinhold, N.; Sander, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors
    Journal Article

    Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save